Hypoparathyroidism Panel
Analyzes 26 genes associated with inherited hypoparathyroidism to help identify genetic cause of parathyroid dysfunction and guide diagnostic evaluation.
Accessed through the DetectHypopara™ Sponsored Testing Program•Sponsored by Calcilytix Therapeutics•Performed by Prevention Genetics
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
The DetectHypopara™ program offers no-charge 26-gene panel testing for U.S. or Canadian patients with non-surgical or idiopathic hypoparathyroidism, hypocalcemia of suspected genetic origin, or a family history of genetic hypoparathyroidism.
When to consider this test
Patient selection
- Residency: Patient resides in the U.S. or Canada.
- Clinical criteria:
- Diagnosis of non-surgical hypoparathyroidism, idiopathic hypoparathyroidism, or
- Hypocalcemia suspected to be genetic, or
- Family history of genetic hypoparathyroidism.
- Ordering requirements: Test must be ordered by a licensed health care provider.
Workflow
How to use this program
- 1
Assess Eligibility
Review the patient’s diagnosis or clinical concern and confirm they meet residency and program criteria before discussing the test.
- 2
Order the Test
Submit the order using the appropriate U.S. TRF or Canada TRF, ensuring all necessary clinical and demographic information is complete.
- 3
Collect and Label Specimen
Collect the specimen in the correct tube and label containers with at least two identifiers. Specimens are accepted Monday–Saturday; holiday schedules apply.
- 4
Review and Discuss Results
Results are typically available about 18 days after specimen and paperwork receipt. Review findings with the patient and caregiver as appropriate.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Prevention Genetics, a CLIA-certified laboratory (CLIA 52D2065132) and College of American Pathologists (CAP) certified laboratory (CAP 7185561). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
Which patients are eligible?
Eligible patients reside in the U.S. or Canada and have one of the following:
• Non-surgical hypoparathyroidism
• Idiopathic hypoparathyroidism
• Hypocalcemia suspected to be genetic in origin
• A family history of genetic hypoparathyroidism
Testing must be ordered by a licensed provider.
What does the panel include?
A 26-gene panel covering parathyroid gland development, PTH secretion, and inherited causes of hypocalcemia. This supports evaluation of possible genetic hypoparathyroidism.
How do I order the test?
Order online using the link provided, or submit the appropriate U.S. or Canada test requisition form (TRF) with all required clinical and demographic details.
What are the specimen requirements?
Collect the specimen in the appropriate tube and label containers with at least two identifiers (name, DOB, or ID). Specimens are accepted Monday–Saturday; holiday schedules are posted in advance.
Is genetic counseling included?
Yes. Post-test genetic counseling is available at no charge through Genome Medical, provided as part of the program.
How do I refer a patient for counseling?
You can refer by:
• Completing and faxing the Genome Medical Genetic Counseling Referral Form, or
• Filling out the post-test counseling section on the PreventionGenetics TRF.
Genome Medical typically contacts patients within 24–48 hours to schedule.
What is the typical turnaround time?
Results are generally available about 18 days after PreventionGenetics receives the specimen and completed paperwork.
See an issue with this program?